IFFIm rating action by Standard & Poor’s follows sovereign donor downgrades

Standard & Poor’s downgrades the International Finance Facility for Immunisation Company by one notch from AAA to AA+

IFFIm and World Bank renew commitment to raise funds for GAVI programmes

IFFIm announces the renewal for five years of its Treasury Management Agreement with the World Bank

New IFFIm vaccine bonds issued to support life-saving immunisation in poorest countries

Bonds will support GAVI Alliance vaccine programmes THIS DOCUMENT IS NOT AN OFFER FOR THE SALE OF SECURITIES. THIS DOCUMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, IN OR INTO, DIRECTLY OR INDIRECTLY, THE UNITED STATES

IFFIm issues first vaccine bonds of 2011

The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons.

Kenya marks the global roll out of pneumococcal vaccine

Pneumococcal vaccines on their way to more than 40 developing countries   

IFFIm successfully prices its inaugural benchmark in Australian Dollars

The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons.

Fitch affirms IFFIm at 'AAA'; outlook stable